Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Open Access
- 7 September 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9695
Abstract
The research in neuroimmunomodulation aims to shed light on the complex relationships that exist between the immune and neurological systems and how they affect the human body. This multidisciplinary field focuses on the way immune responses are influenced by brain activity and how neural function is impacted by immunological signaling. This provides important insights into a range of medical disorders. Targeting both brain and immunological pathways, neuroimmunomodulatory approaches are used in clinical pain management to address chronic pain. Pharmacological therapies aim to modulate neuroimmune interactions and reduce inflammation. Furthermore, bioelectronic techniques like vagus nerve stimulation offer non-invasive control of these systems, while neuromodulation techniques like transcranial magnetic stimulation modify immunological and neuronal responses to reduce pain. Within the context of aging, neuroimmunomodulation analyzes the ways in which immunological and neurological alterations brought on by aging contribute to cognitive decline and neurodegenerative illnesses. Restoring neuroimmune homeostasis through strategies shows promise in reducing age-related cognitive decline. Research into mood disorders focuses on how immunological dysregulation relates to illnesses including anxiety and depression. Immune system fluctuations are increasingly recognized for their impact on brain function, leading to novel treatments that target these interactions. This review emphasizes how interdisciplinary cooperation and continuous research are necessary to better understand the complex relationship between the neurological and immune systems.Keywords
This publication has 424 references indexed in Scilit:
- Astrocyte immunosenescence and deficits in interleukin 10 signaling in the aged brain disrupt the regulation of microglia following innate immune activationGlia, 2022
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic NeuropathyJAMA Neurology, 2021
- Challenges and opportunities in translational pain research – An opinion paper of the working group on translational pain research of the European pain federation (EFIC)European journal of pain, 2021
- A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout FlaresArthritis & Rheumatology, 2021
- Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessmentDepression and Anxiety, 2021
- Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Traditional agentsMuscle & Nerve, 2019
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II DepressionJAMA Psychiatry, 2019
- Altered serum levels of TNF-α, IL-6, and IL-18 in depressive disorder patientsHuman Psychopharmacology: Clinical and Experimental, 2017
- Associations between pro‐inflammatory cytokines, learning, and memory in late‐life depression and healthy agingInternational Journal of Geriatric Psychiatry, 2017
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant DepressionJAMA Psychiatry, 2013